Skip to main content
. 2022 Apr 28;12:861807. doi: 10.3389/fonc.2022.861807

Figure 1.

Figure 1

METTL3 is overexpressed and related to poor prognosis in GC. (A) METTL3 mRNA expression was evaluated in TCGA GC cohort. (B) METTL3 mRNA expression was evaluated in clinical GC samples. (C) Representative IHC stains of METTL3 in clinical GC samples. (D) METTL3 expression was measured in gastric epithelial cell and GC cell lines. (E–G) OS (E), PFS (F), and PPS (G) were analyzed in GC patients according to METTL3 expression. ***P < 0.001.